throbber
Acta Neuropathol (1992) 83: 584 - 589
`
`.__
`
`© Springer-Verlag 1992
`
`Comparison of behavior in muscle fiber regeneration
`after bupivacaine hydrochloride- and acid
`anhydride-induced myonecrosis
`C. Akiyama1, 2, S. Kobayashi1, 3, and I. Nonakal
`1 National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187, Japan
`2 Department of Pediatrics, Fukuoka University, School of Medicine,
`3 Department of Pediatrics, Jichi Medical School,
`
`Received July 22, 1991/Revised , accepted December 2, 1991
`
`Summary. We compared the morphologic characteris(cid:173)
`tics of muscle fiber necrosis and subsequent regenera(cid:173)
`tion after injury induced by intramuscular injections of
`bupivacaine hydrochloride (BPVC) and a variety of
`solutions at acid and alkaline pH (acetic anhydride,
`citric acid buffer, and sodium carbonate buffer). After
`BPVC injection the necrotic muscle fibers were rapidly
`invaded by phagocytic cells, followed by active regener(cid:173)
`ation and very little fibrous scar formation. The regen(cid:173)
`erating muscle fibers increased rapidly in size and
`attained complete
`fiber
`type differentiation and
`regained their initial fiber diameter within 1 month.
`Both alkaline and acid solutions induced muscle fiber
`necrosis followed by regeneration. Fiber necrosis
`induced by alkaline buffers and acetic anhydride solu(cid:173)
`tions above pH 5.0 produced changes quite similar to
`that induced by BPVC. However, injection with 0.1 M
`acetic anhydride at pH below 4.0 resulted in coagulative
`necrosis of the injured muscle with very little phagocytic
`infiltration with poor regenerative activity and dense
`fibrous tissue scarring. Thus, pH 4.0 appears to be the
`critical pH determining the type of muscle injury and
`subsequent poor pbagocytic and regenerative activities.
`This model of acidic acetic anhydride injury may lead to
`the identification of factors which interfere with regen(cid:173)
`eration and cause fibrous tissue scarring in human
`muscular dystrophy.
`
`Key words: Muscle necrosis - Regeneration - Fibrosis -
`Bupivacaine - Acid anhydride
`
`Skeletal muscle fibers undergo necrosis after mechanical
`and chemical injuries including crush, ischemia, cold or
`heat injuries, and injections of local anesthetics and
`snake toxins [1, 8]. The necrotic fibers are then invaded
`and cleared by phagocytic cells followed by an active
`regenerative process. The mechanism to activate satel-
`
`Offprint requests to: C. Akiyama (address see I above)
`
`lite cells, which play an important role in muscle fiber
`regeneration, is not yet known.
`One might ask what environmental factors are
`necessary to induce phagocytosis, and what the fate of
`necrotic fibers may be if phagocytosis is less active. To
`answer these questions we injected various chemicals at
`different pH into rat muscles and examined the behavior
`of necrotic and regenerative processes by means of
`muscle histochemistry with roorphometric analysis and
`electron microscopy.We found that acid anhydride (AA)
`solution at a pH less than 4.0 caused extensive myone(cid:173)
`crosis , with no apparent phagocytic activity and poor
`regeneration. On the other band , bupivacaine hydro(cid:173)
`chloride (BPVC; Marcaine), a local anesthetic, caused
`necrosis with marked phagocytic activity followed by
`rapid muscle fiber regeneration (3, 5, 13-16, 20, 23). We,
`therefore, carried out a study comparing muscle degen(cid:173)
`erative and regenerative processes after injury with
`BPVC and AA to identify factors which promote or
`inhibit muscle fiber regeneration.
`
`Materials and methods
`
`Male Wistar rats weighing 200- 250 g were used. The right soleus
`(red) and tibialis anterior (TA; white), muscles were surgically
`exposed under general anesthesia and various chemical solutions,
`listed in Table 1, were injected directly into the muscles with a thin
`gauge needle. The chemical solutions included 0.5 ml 0.5 % BPVC,
`0.1 M sodium carbonate at pH varying from 9.0 to 11.0, 0.1 M
`citric acid at pH 5.0- 3.0, 0.1 M AA at pH 3.0, 0.1 M AA solution
`whose pH was adjusted between 3.0 and 6.0 with 0.1 M NaOH, and
`0.5 % - 5 % AA in 0.85 % saline. The contralateral soleus and TA
`muscles of each rat received saline in the same manner and served
`as controls. In each trial, 2-3 rats were examined .
`To study the necrotizing process, the soleus muscles were taken
`from 2 each of 64 rats at 15 and 30 min, and 1, 2, 6, 12, 24, and 48 h
`after the injections of BPVC, and 0.1 M AA at pH 3.0, 4.0 and 5.0,
`respectively. Each muscle was examined by histochemistry and
`electron microscopy. For electron microscopy, the soleus muscle
`specimen was fixed in 0 .1 M sodium cacodylate-buffered glutaral(cid:173)
`dehyde solution at pH 7.4 for 3-4 h . The tissue was washed in the
`same buffer solution, post-fixed in 1 % OsO4 and embedded in
`epoxy resin after dehydration in serial alcohol solutions.
`
`FRESENIUS EXHIBIT 1056
`Page 1 of 6
`
`

`

`Table 1. Myoto>..ic agents
`
`Chemicals
`
`0.5 % bupivacaine hydrochloride
`0.1 M sodium carbonate buffer
`0.1 M citric acid buffer
`0. 1 M acetic anhydride buffer
`0.1 M acetic anhydride + NaOH
`
`0.5 % , 1 % , 3 % , 5 % , acetic anhydride
`(<pH3.0)
`
`585
`
`pH
`
`6.5
`9.0, 11.0
`5.0, 3.0
`3.0
`
`3.0
`4.0
`4.1
`4.3
`5.0
`3.0
`
`Myonecrosis
`(48 h)
`
`Phagocytosis
`(48 h)
`
`Regeneration
`(10 days)
`
`++ +
`+
`+++
`++ +
`
`++ +
`++ +
`++
`+
`+
`++ +
`
`+++
`+++
`++
`
`++
`++
`+++
`
`F
`F
`M
`p
`
`p
`p
`M
`M
`F
`p
`
`- , none; +,localized;+ + , moderate;++ +, marked; F, fair; M, moderate; P, poor
`
`To study muscle fiber regeneration, the soleus and TA muscles
`were taken from 5 animals each at 2, 3, 7, 10, 15, 20, and 30 days
`after injection from the two groups treated with BPVC and 0.1 M
`AA at pH 3.0 (total = 70 rats). In 2- 3 rats from each of the
`remaining groups listed in the Tobie 1, the treated muscles were
`examined at 2 and 10 days after the injection.
`The soleus and TA muscles were immediately frozen in
`isopenrane cooled in liquid nitrogen. Serial frozen sections were
`stained with hematoxylin and eosin (H&E), modified Gomori
`trichrome, and a battery of histochemical methods including
`NADH -TR, routine ATPase and ATPase with preincubation at pH
`4.5 and 4.3, acid phosphatase, nonspecific esterase (NSE), and
`acridine orange (AO). To measure muscle fiber diameters and to
`
`determine fiber types, 100-200 fibers in each muscle were analyzed
`in photographs from serial frozen sections printed at a final
`magnification of x 660.
`
`Results
`
`Muscle fiber necrosis
`
`As shown in Table 1, various chemicals (especially
`BPVC and acidic solutions below pH 4.0) caused muscle
`fiber necrosis. Immediately after BPVC injection,
`
`Fig. 1. Soleus muscles 48 h after bupivacaine hydrochloride
`(BPVC) (A) and acid anl1ydride (AA) at pH 3.0 (B) injections.
`Numerous necrotic fibers are invaded by phagocytic cells iu the
`BPVC-treated muscle (A). Although the contour of fibers is
`
`preserved, myofibrillar networks have disappeared and myonuclei
`were granulated (B). Note no macrophage invasion in extra- and
`intracellular spaces (B). A, B H&E, x 240
`
`FRESENIUS EXHIBIT 1056
`Page 2 of 6
`
`

`

`586
`almost all the muscle fibers in the treated soleus and TA
`underwent massive necrosis characterized by opaque
`fibers and empty sarcolemmal tubes, with foci of hyper(cid:173)
`contraction bands on longitudinal sections. The necrotic
`fibers were invaded by acid phosphatase-positive macro(cid:173)
`phages within 12 h after the injection. At 24 and 48 h,
`the necrotic fibers and the extracellular space were filled
`with numerous mononuclear phagocytic cells as well as
`some polymorpbonuclear leukocytes (Fig. l A).
`
`Fig. 2. An electron micrograph of a necrotic fiber 15 min after AA
`at pH 5.0 injection. The myofibrils are disrupted and organelJes
`swollen. T he sarcolemma has focally disappeared. x 24000
`
`Almost all the muscle fibers treated with dtric acid
`and sodium carbonate buffers, A A and AA buffers
`showed extensive necrosis. The appearance of the
`necrotic fibers treated with citric and sodium carbonate
`buffers was similar to those seen in BPVC-treated soleus
`muscles.
`On the other hand, in the muscle injected with AA
`below pH 4.0 and AA buffer at pH 3.0 the necrotic
`muscle fibers had faintly staining cytoplasm with loss of
`the intermyofibrillar networks and myonuclei. Muscle
`fiber necrosis after 0.5 % , 1 % , 3 % , and 5 % AA
`injections had a similar appearance. In the muscles
`treated with such strong acidic solutions, the contour of
`necrotic fibers remained unchanged with little pbagocyt(cid:173)
`ic activity even 24 and 48 h after injection (Fig. lB). The
`blood vesseles and peripheral nerve bundles in the
`interstitium were not clearly identifiable.
`
`Electron microscopy of necrotic fibers
`
`Fifteen minutes after BPVCand 0.1 MAA at pH 4.0 and
`5.0 injections, electron microscopy revealed disruption
`of the myofibrils with the formation of hypercontraction
`bands, and the sarcoplasmic reticulum appeared to be
`dilated (Fig. 2). There was focal loss of plasmalemma.
`A t 2 h , myofibrils were fragmented at the level of the
`Z-line (Fig. 3A) . The basal lamina and :satellite cells
`were well preserved at all stages. At 48 h, many
`phagocytic cells were found in the extra- and intracellu(cid:173)
`lar spaces, and satellite cells were activated.
`
`Fig. 3. Soleus muscle 2 h after AA at pH 5.0 (A) and at 3.0 (B) injections. Myofibrils are fragmented from a selective Z.line dissolutio n
`(A). The myofibrils are fragmented at va1ious levels of the sarcomeres including the Z.line, A and I bands (B). A, B x 6 000
`
`FRESENIUS EXHIBIT 1056
`Page 3 of 6
`
`

`

`In the muscle treated with O .1 M AA at pH 3. 0, there
`was disruption of both the basal lamina and plasma
`membrane 15 min after the injection. TI1ere was degen(cid:173)
`eration of both muscle fibers and satellite cell nuclei with
`loss of chromatin granules (Fig. 4). At 2 h, the myofi(cid:173)
`brils were fragmented at different levels of the myofibrils
`
`Soleus (red)
`
`60 I '6
`
`--·------·
`
`Untreated
`
`- - - - -
`
`60
`
`30
`
`587
`
`Tibialis anterior (white)
`
`---------
`---
`
`--------
`--
`
`A
`
`7 10
`
`15
`
`30
`
`7 10
`
`15
`
`30
`
`60
`
`.I
`]
`u::
`
`'O
`
`60
`
`-~z-:
`....
`------- - 30
`
`~
`
`- - - - - - -
`
`_..,....-----
`------
`----
`
`Fig. 4. Soleus muscle 15 min after AA at pH 3.0 injection. The
`basal lamina and plasma membrane have disappeared. Satellite
`cells are also degenerated. X 12 000
`
`B
`
`7 10
`
`15
`
`7 10
`30
`Days after injection
`
`15
`
`30
`
`Fig. S. Although the regenerating fibers (--0-) treated with BPVC
`(A) rapidly recovered and regained their initial size in both soleus
`(red) and tibialis anterior (white) muscles, when treated wit h AA
`solutio n at pH 3.0 (B) they showed markedly delayed recovery.
`One standard deviation of the mean control (untreated) fiber
`diameter (....._) is indicated by dotted lines
`
`4
`
`•
`·-
`,
`
`114
`
`" )
`,,,,,
`./
`
`... ,
`
`•
`
`•
`
`•
`...
`.,
`;.
`
`.
`-...
`,
`
`t
`'
`
`'
`
`.
`. •
`..
`.. ,
`"
`.
`
`r ..
`
`'-
`
`.--
`,
`
`• •
`
`--
`
`~
`
`(
`
`'k...
`
`'
`
`...
`
`-'
`-~
`. _,
`
`'I.
`
`'
`
`\ ..
`. ,#
`'
`v ·
`•
`.
`•
`- -
`.
`B
`.,
`
`\
`•
`
`·,
`
`l I
`I
`
`•
`
`, ~
`,, ti
`
`1
`~ ~'-.
`•
`-
`•
`'
`•
`
`..
`
`-~
`
`\
`
`..
`Fig. 6 A, B. At 30 days after BPVC injection. Centrally placed nuclei are seen in almost all of the regenerating fibers in both soleus (A) and
`tibialis anterior (B) muscles. H&E, x 240
`
`'>.,,.
`; ~ ....
`,, .
`l
`"
`,. .... ! -
`...
`-"!:"
`~ , . ....._. I
`....
`r -,-:--..
`•
`....
`"'"'
`... . ~
`•
`'
`~ ..
`. '
`~. ..
`• .. . . ...
`. ·'
`• ,
`'
`.
`- · t
`' / '
`•l''-.
`\
`,,
`•,7/
`,,
`•
`__ \
`~-
`-,, ,
`
`•
`
`"'-'-.. ""
`
`l ..
`
`•
`
`<I
`
`'
`
`-,co
`
`,,~
`
`~
`
`:
`
`•
`
`"II
`
`~
`
`0
`
`~
`
`#
`
`I'-
`
`\"~
`.,. •.
`,,,
`..
`'• ~. #
`.. . ..,
`. .,,,,..
`,,.
`'
`'
`
`V,
`
`I
`
`✓
`
`FRESENIUS EXHIBIT 1056
`Page 4 of 6
`
`

`

`588
`including the Z-line, A and I bands (Fig. 3B). Even 48 h
`after the injection, no phagocyticcells had appeared and
`the fragmente d myofibrils remained unchanged from
`those at 2 b.
`Muscle fiber degeneration in the soleus muscles
`treated with these three different chemicals is summa(cid:173)
`rized in Table l.
`
`Muscle fiber regeneration
`
`In BPVC-treated TA and soleus muscles, small caliber
`regenerating fibers with basophilic cytoplasm and cen(cid:173)
`trally placed vesicular nuclei appeared in a pool of
`mononuclear cells 72 h after the injection on H&E.
`After 7 days, numerous regenerating fibers charac(cid:173)
`terized by basophilic cytoplasm, vesicular nuclei and
`prominent nucleoli were clearly identifiable. The regen(cid:173)
`erating fibers regained their initial diameter within
`30 days , but the recovery of the white muscle was
`slightly slower than that of the red muscle (Fig. 5). At
`30 days, almost all of the regenerating fibers still
`retained their centrally placed nuclei (Fig. 6).
`As expected from the behavior of myonecrosis, there
`was a marked delay in muscle fiber regeneration in
`necrotic muscles treated with strong AA solution below
`pH 4.0. Seven days after the injection, there were only a
`few small fibers with histologic characteristics of regen(cid:173)
`erating fibers and numerous necrotic fibers with very
`little phagocytic activity remained. Fifteen days after
`AA injection, regenerating fibers were still of small
`caliber and they were embedded in the fibrotic tissue
`scar (Fig. 7) .
`
`Histochemical characteristics of regenerating fibers
`
`The histochemical characteristics of regenerating fibers
`in soleus and TA muscles treated with BPVC are
`
`Fig. 7. Soleus muscle 30 days after AA at pH 3.0 injection . The
`regenerating fibers are small with variation in fiber size. Note
`increased fibrous tissue proliferation. H&E, x 240
`
`Soleus (red)
`
`Tiblalis anterior (wMe)
`
`Basophllia
`
`Central
`nuclei
`
`ATPase
`
`Acridine
`orange
`
`Nonspecific
`esterase
`
`7
`
`15
`
`7
`30
`Days after injection
`
`15
`
`30
`
`Fig. 8. Except for slightly delayed muscle fiber type differentiation
`on ATPase staining, there are no histochemical differences in
`regenerating fibers between white and red muscle
`
`summarized in Fig, 8. At 3 days, small regenerating
`fibers already showed strong orange fluorescence with
`AO staining, and high enzyme activities for NSE, acid
`phosphatase and NADH-TR. AO-positive fibers were
`no longer found at 15 days. The activities of acid
`phosphatase and NSE returned to normal by 15 days.
`Regenerating fibers initially had the characteristics of
`undifferentiated type 2C fibers by ATPase staining, and
`they began to differentiate at 10 days in TA and at
`15 days in soleus. Fiber type differentiation was com(cid:173)
`pleted by 20 days in TA and by 30 days in soleus
`(Fig. 8).
`
`Discussion
`
`There have been a number of reports indicating that
`regenerative activity of muscle fibers following necrosis
`is best studied in BPVC-induced muscle injury, because
`BPVC preferentially damages the muscle membrane but
`spares the basement membrane, blood vessels and
`peripheral nerves [3, 20, 23]. Red muscle fibers are
`more susceptible to BPVC damage than white [3]. The
`regenerating fibers are almost uniform in size, and the
`total regenerative process is readily reproducible (20].
`To determine the histologic profiles of necrotic and
`regenerating fibers after myonecrosis in both red and
`white muscles, we injected BPVC into the rat soleus
`(red) and TA (white) muscles. The behavior of muscle
`fiber regeneration in the present study is quite similar to
`that seen in chicken muscle treated with BPVC [21].
`To identify the factors which reduce regenerative
`capacity we injected various alkaline and acid solutions
`into the rat muscles. Except for strong acidic solution&
`including AA below pH 4.0 and AA buffer solution at
`pH 3.0, all solutions induced myonecrosis with phago(cid:173)
`cytosis followed by rapid regeneration, as seen in
`BPVC-treated muscles. Our study confirmed that 0.1 M
`AA below pH 4.0 induced myonecrosis, but interfered
`with factors which stimulate phagocytic activity. Less
`active phagocytosis appeared to inhibit muscle fiber
`regeneration, whereas massive phagocytosis in BPVC(cid:173)
`injured muscle induced rapid fiber regeneration, sug-
`
`FRESENIUS EXHIBIT 1056
`Page 5 of 6
`
`

`

`gesting that persistence of necrotic material inhibits the
`following regeneration [12].
`The basal lamina and satellite cells in muscles treated
`with BPVC and AA at pH 5.0 were well preserved, with
`preferential damage to the muscle membrane and
`dissolution of the myofibrils at the Z-line, probably
`induced by a certain proteolytic process. On the other
`hand , in muscles treated with strong acidic solution
`below pH 4.0, all intracellular organelles, satellite cells,
`and blood vessels were damaged, and myofibrils were
`disrupted at various levels of the sarcomere. The process
`of muscle fiber damage induced by the strong acidic
`solution is not proteolytic in nature but causes coagula(cid:173)
`tion of the protein. Following coagulative necrosis of
`muscle fibers, phagocytosis is limited, regenerative
`activity is reduced, and dense interstitial fibrosis fol(cid:173)
`lows. The necrotizing process in BPVC- and pH 5.0
`AA-injured muscles was similar to that seen in various
`muscle diseases including progressive muscular dystro(cid:173)
`phy [4, 6, 9, 19, 22).
`Muscle fiber regeneration in muscle treated with
`alcohol/oil emulsion was slower than that in BPVC(cid:173)
`treated muscles [10], fib rous tissue was increased in
`amount, and most muscle fibers in the regenerating
`region were still small 6 weeks after injury. Fibrous tissue
`proliferation also occurs after crush injury (18], after
`repeated injections of chlorpromazine [7] and even local
`anesthetics [2, 5]. Thus, delayed regenerative velocity
`may induce interstitial fibrous tissue proliferation or
`vice versa.
`In progressive muscular dystrophy, the disease pro(cid:173)
`gresses without interruption despite an active regenera(cid:173)
`tive process because muscle fiber degeneration is not
`fully compensated by muscle fiber regeneration. Certain
`environmental factors, including interstitial fibrosis
`which impairs the blood supply to individual regenerat(cid:173)
`ing fibers, are probably responsible for reducing the
`regenerative capacity [17]. As suggested from the
`present study, the slow regenerative velocity might
`induce further interstitial fibrosis. This vicious cycle
`seems to be responsible for progression in progressive
`muscular dystrophy.
`
`References
`
`l . Allbrook D (1981) Skeletal muscle regeneration. Muscle
`Nerve 4:234-245
`2. Basson MD, Carlson BM (1980) Myotoxicity of single and
`repeated injections of mepivacaine (Carbocaine) in the rat.
`Anesth Analg 59:275- 282
`3. Benoit PW, Belt WD (1970) Destruction and regeneration of
`skeletal muscle after treatment with a local anesthetic, bupi(cid:173)
`vacaine (Marcaine). J Anat 107:547- 556
`
`589
`
`4. Bonilla E, Schotland DL, Wakayama Y (1978) Duchenne
`dystrophy: focal alterations in the distribution of concanavalin
`A binding sites at the muscle cell surface. Ann Neurol
`4:117- 123
`5. Bradley WG (1979) Muscle fiber splitting. In: Mauro A (ed)
`Muscle regeneration. Raven Press. New York, pp215- 232
`6. Bradley WG, Fulthorpe JJ (1978) Studies 6f sarcolemmal
`integrity in myopathic muscle. Neurology 28:670-677
`7. Brnmback RA, Empting L, Susag ME, Staton RD (1982)
`Muscle fibrosis associated with intramuscular chlorpromazine
`administration. A preliminary report. J Pharm Pharmacol
`34:526- 528
`8. Carlson BM (1973) T he regeneration of skeletal muscle - a
`review. A m J Anat 137:119- 150
`9. Carpenter S, Karpati G (1979) Duchenne muscular dystrophy.
`Plasma membrane loss initiates muscle cell necrosis unless it is
`repaired. Brain 102:147- 161
`10. Dhoot GK, Perry SV (1982) Changes in the forms of the
`components of the troponin complex during regeneration of
`injured skeletal muscle. Muscle Nerve 5:39- 47
`11. Grim M , Rerabkova L, Carlson BM (1988) A test for muscle
`lesions and their regeneration following intramuscular drug
`application. Toxicol Pathol 16:432- 442
`12. Grounds JvlD (1987) Phagocytosis of necrotic muscle in muscle
`isografts is influenced by the strain , age, and sex of host mice. J
`Pathol 153:71- 82
`13. Hall-CraggsECB (1974) Rapid degeneration and regeneration
`of a whole skeletal muscle following treatment with bupiva(cid:173)
`caine (Marcain). Exp Neurol 43:349-458
`14. Hall-Craggs ECB, Seyan HS (1975) H istochemical changes in
`innervated and denervated skeletal muscle fibers following
`treatment with bupivacaine
`(Marcain). Exp Neurol
`46:345- 354
`15. Jirmanova S, Thesleff S (1972) Ultrastructural study of exper(cid:173)
`imental muscle degeneration and regeneration in the adult rat.
`Z Zellforscb 131:77- 97
`16. Jones GH (1982) Protein synthesis in bupivacaine (Marcaine )(cid:173)
`treated,
`regenerating skeletal . muscle. Muscle Nerve
`5:281-290
`17. Lipton BH (1979) Skeletal muscle regeneration in muscular
`dystrophy. In: Mauro A (ed) Muscle regeneration. Raven
`Press, New York, pp 31- 40
`18 . McGeachieJK, Grounds MD (1987) Initiation and duration of
`muscle precursor replication after mild and severe injury to
`skeletal muscle of mice. Cell Tissue Res 248:125- 130
`19. Mokri B, Engel AG (1975) Duchenne dystrophy: electron
`microscopic fiodings pointing to a basic or early abnormality in
`the plasma membrane of the muscle fiber. Neurology
`25:1111- 1120
`20. Nonaka I, Takagi A, lshiura S, Nakase H, Sugita H (1983)
`Pathophysiology of muscle fiber necrosis induced by bupiva(cid:173)
`caine hydrochloride (Marcaine). Acta Neuropathol (Berl)
`60:167-174
`21. Nonaka I. Fujita T, Sugita H (1984) Regenerative capability of
`skeletal muscle in chicken muscular dystrophy. Muscle Nerve
`7:400- 407
`22. Schmalbruch H (1975) Segmental fibre breakdown and defects
`of the plasmalemma in diseased human muscles. Acta Neuro(cid:173)
`pathol (Berl) 33: 129-141
`23. Sokoll MD, Sonosson B, Thesleff S (1968) Denervation
`changes produced in an innervated skeletal muscle by long(cid:173)
`continued treatment with a local anesthetic. Eur J Pharmacol
`4:179- 187
`
`FRESENIUS EXHIBIT 1056
`Page 6 of 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket